In late April 2026, Ecolab reported higher first-quarter revenue of US$4,066.1 million and net income of US$432.6 million, ...
ST. PAUL, Minn. & WALTHAM, Mass.--(BUSINESS WIRE)-- Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on ...
Building on the continued growth and strong performance of its Life Sciences business, Ecolab is further expanding its global bioprocessing capabilities to support biopharmaceutical manufacturers ...
New solution reduces time and costs to meet the modern demands of pharmaceutical production ST. PAUL, Minn.--(BUSINESS WIRE)-- Ecolab Life Sciences today announced the launch of its Klercide™ Rapid ...
Ecolab opens Asia bioprocessing facility in South Korea, offering downstream process development support to biopharmaceutical ...
Ecolab’s new BPAL was created to help enable manufacturers to address process challenges earlier and reduce development risk.
Purolite™ AP+50 resin enables improved cost efficiencies in antibody manufacturing ST. PAUL, Minn.--(BUSINESS WIRE)-- Ecolab Life Sciences today announced it has launched an innovative new resin to ...
Ecolab Inc. (NYSE:ECL) is one of the best basic materials stocks to invest in. On June 16, Ecolab Life Sciences announced the launch of Purolite AP+50 resin, which features a 50-micron bead size and ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Life Sciences today announced the launch of its Klercide™ Rapid Sporicide, a new sporicidal disinfectant designed to elevate pharmaceutical cleanroom safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results